A comprehensive analysis of advanced kidney cancer tumors from the IMmotion151 trial provided new insights on the tumor features that underpin responses to therapy.
If the current COVID-19 trends persist, the NCI estimates that the pandemic’s impact could threaten the trend of annually decreasing cancer mortality seen in the US since 1990.
Investigators summarize current literature surrounding the treatment of NLPHL and discuss treatment considerations for 2 clinical cases.
Even patients with bulky disease had no difference in survival after chemotherapy, provided their PET scan was negative.
Storing and administering a COVID-19 vaccine presents logistical challenges for many small practices and rural clinics.
Overall incidence of prostate cancer decreased between 2003 and 2017.
Late diagnosis of breast cancer significantly impacts survival — and men are generally diagnosed with breast cancer at more advanced stages.
Despite relying on glycolysis, there is growing evidence that many tumor types still have high levels of mitochondrial energy metabolism and functioning oxidative phosphorylation. One such subset of tumors is melanoma, potentially playing a role in both tumor progression and resistance to therapy. This has led researchers to wonder whether targeting mitochondrial respiration could be…
Sometimes the distinctions between cancer treatment groups are a little blurry. Here’s a guide to their definitions and origins.
In addition to age, sex, and comorbidities, a new study flagged uncontrolled cancer and renal insufficiency as key prognostic factors for COVID-19 outcomes.
Telemedicine has become more crucial than ever in the continuing wake of the COVID-19 pandemic. Research from the US Centers for Disease Control and Prevention (CDC) showed that there was a 50% increase utilization of telehealth services in the first quarter of 2020 compared with 2019, and a 154% increase in week 13 of 2020…
RCC vaccines are predominantly being developed using autologous tumor cells, dendritic cells, genetically modified tumor cells, and peptides.
How effective is surgical treatment for ductal carcinoma in situ (DCIS) at preventing an invasive recurrence of breast cancer? Treatment is intended to significantly lessen the lifetime risk of breast cancer and breast cancer-related mortality, but are patients diagnosed with DCIS still at risk for experiencing poor outcomes? A recent study in JAMA Network Open…
Preferences are tied not just to the experience of receiving an injection, but also to factors related to a patient’s access to different types of care settings.
Phase 3 clinical trial of paclitaxel and atezolizumab shows no significant survival benefit, but questions remain over FDA decision to issue safety alert.